Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Solu Therapeutics, Inc

Clinical trials sponsored by Solu Therapeutics, Inc, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New hope for tough blood cancers: first human trial launches Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New hope for tough blood cancers: first human trial launches

Disease control Recruiting now

This study tests a new drug called STX-0712 in people with advanced types of blood cancer (CMML or AML) who have run out of standard treatments. The main goal is to find a safe dose and see how the body handles the drug. About 105 participants will take part in this early-phase t…

Phase 1 • Sponsor: Solu Therapeutics, Inc • Aim: Disease control

Last updated Jun 27, 2026 09:03 UTC